5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases
US8975250B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 2012 |
| Grant date | Mar 10, 2015 |
| Priority date | — |
| Expiry date | Jul 9, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to 5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives having Formula (I)as defined herein, their preparation and their therapeutic use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.